Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer

NCT07492927 · clinicaltrials.gov ↗

RECRUITING

Status

1700

Enrollment

OTHER

Sponsor class

Conditions

Clinically Significant Prostate Cancer

Sponsor

Xijing Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]